HUB
HUB
Brussels, Belgium1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer | Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma; Gastric Cancer Adenocarcinoma Metastatic | Recruiting | Phase 2 | 2025-12-22 | NCT06962137 |